good news on oxo bio5 Nov 2018 08:15
add in the d2p rapid growth and we have a nicely developing growing global product line 👍
'the unnoticed mammoth sneaking under the hearth rug in front of everybody's eyes is.... D2P...
''Revenues from the Group's d2p anti-microbial technologies increased significantly to £0.5 million for the six months to 30 June 2018 (H1-2017: £0.0 million)''
D2P globally, domestically, pharmaceutically, industrially, there's $BILLIONS in that! There's no legislation involved!!!!
And breaking the US with their first cargo order was significant on a scale of magnitude as ever totally ignored by the investing public. D2P will be SYM's saviour and superhero. The $billion market cap will come from D2P first, D2W second...
Revenues from Symphony's d2p "designed-to-protect" technologies are significantly ahead of last year, and are expected to comfortably exceed management expectations. In Italy, our range of d2p anti-microbial gloves are listed in several large, as well as some smaller, retail outlets. Promotion campaigns are scheduled by our distributor during this October and further increases to product listings are expected to continue over the coming months.
After some smaller initial orders, the Group has now also received its first full $60,000 container order for d2p anti-microbial gloves to the USA.
''Also, and after two years of R&D and successful trials, Symphony has received an initial commercial order for d2p anti-insect additive technology with a very large global manufacturer of commercial agricultural products. The value of this first part-container order is $120,000, and the finished products made with d2p technology will be marketed globally. ''